Targeting the Highly Deleterious G161C and Y260C SNP Variants of the AGXT Protein Involved in Glyoxylate Metabolism Using Tauroursodeoxycholic Acid: A Computational Study.

Shruthika Giridharan, Vasundra Vasudevan, Sidharth Kumar Nanda Kumar, Madhana Priya Nanda Kumar, Magesh Ramasamy

Abstract read

In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shruthika GiridharanDepartment of Biotechnology, Faculty of Biomedical Sciences & Technology, Sri Ramachandra Institute of Higher Education and Research (DU), Chennai 600116, India.

Vasundra VasudevanDepartment of Biotechnology, Faculty of Biomedical Sciences & Technology, Sri Ramachandra Institute of Higher Education and Research (DU), Chennai 600116, India.

Sidharth Kumar Nanda KumarDepartment of Biotechnology, Faculty of Biomedical Sciences & Technology, Sri Ramachandra Institute of Higher Education and Research (DU), Chennai 600116, India.ORCID 0000-0002-9202-2201

Madhana Priya Nanda KumarCenter for Transdisciplinary Research, Department of Pharmacology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Chennai 600077, India.

Magesh RamasamyDepartment of Biotechnology, Faculty of Biomedical Sciences & Technology, Sri Ramachandra Institute of Higher Education and Research (DU), Chennai 600116, India.ORCID 0000-0002-9508-8097

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperoxaluria Type 1 (PH1) is a rare autosomal recessive metabolic disorder caused by mutations in the

Indexed as

GlyoxylatesHyperoxaluria, PrimaryPolymorphism, Single NucleotideTaurochenodeoxycholic AcidTransaminasesHumansMolecular Docking SimulationMolecular Dynamics SimulationAlanine-glyoxylate transaminaseGlyoxylatesglyoxylic acidTaurochenodeoxycholic AcidTransaminasesursodoxicoltaurineAGXTDCCMFELhealthcaremolecular dockingmolecular dynamicsneglected diseasePH1SNP variantsTUDCA

Identifiers

PMID42196567

DOI10.3390/ijms27104590

PMCPMC13206818

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.